Headline
The latest stories from AHA Today.
The Food and Drug Administration last week authorized marketing of a rapid diagnostic test to detect Ebola virus antigens in human blood from certain living individuals as well as samples from those recently deceased who are suspected to have died from Ebola.
The Food and Drug Administration Oct. 11 approved a new tablet for the acute treatment of migraine headache pain.
The AHA is accepting nominations through Nov. 25 for its 2020 Dick Davidson NOVA Award, which recognizes outstanding collaboration by hospitals and health systems for healthier communities.
A federal judge in Washington state today blocked nationwide a Department of Homeland Security final rule from taking effect that would limit the ability of legal immigrants to adjust or extend their immigration status or gain full citizenship based on their prospective receipt of public benefits.
The Centers for Disease Control and Prevention today released updated interim clinical guidance for U.S. health care providers evaluating and caring for patients with lung injury associated with use of electronic cigarette or vaping products.
The AHA today urged the Drug Enforcement Administration to explicitly consider drug shortages when setting and adjusting aggregate production quotas, citing concern that the agency’s proposal to reduce 2020 production quotas for five opioid controlled substances would exacerbate shortages of…
The Centers for Medicare & Medicaid Services should require states that propose Medicaid work requirements and other demonstrations to project the cost of administering them, the Government Accountability Office said in a report released yesterday.
The Centers for Medicare & Medicaid Services today published its star ratings for 2020 Medicare Advantage and prescription drug plans.
The Centers for Disease Control and Prevention this week reported a record 2.5 million cases of chlamydia, gonorrhea and syphilis in the U.S. in 2018, including a 40% increase in syphilis among newborns.
The Centers for Medicare & Medicaid Services has updated its alternative payment model participation status tool for the 2019 Quality Payment Program, which identifies eligible clinicians who qualify as advanced APM participants based on Medicare Part B claims data through June.